VANCOUVER, BC / ACCESS Newswire / July 7, 2026 / HM Exploration Corp. ("HM Exploration", "HM" or the "Company") ...
The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with "double-positive" metastatic ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Semiconductors are central to modern technology. They are used in computer chips, solar cells, sensors, LEDs and ...
Upcoming Type B Statistical Methods Meeting expected to set stage for FDA to align with EMA and MHRA on use of Fall 2026 ...
Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at NUS have developed a new method that allows ...
Immuron Engages Pullan Consulting to Advance IMM-529 Partnering Strategy; Immuron is seeking a partner to support clinical development through regulatory approval and ...
Imperial researchers are now planning these systems as part of an international push to create a new generation of quantum ...
Abstract: Model predictive current control (MPCC) and model predictive torque control (MPTC) are two derivatives of model predictive control. These two control methods have demonstrated their ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced results from two Phase 1/2 ...
The NCTA is using drone-based LiDAR and CPM scheduling to improve construction oversight, safety, and progress tracking.
Rafael Holdings is a small, high-risk biotech company that is at the most vital juncture of its corporate history. See why I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results